Literature DB >> 1436307

Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate).

M Fischbach1, G Hamel, U Simeoni, J Geisert.   

Abstract

Phosphate dialytic removal (PDR) depends in part on the type (acetate or bicarbonate) and the concentration of the buffer dialysate. Plasma phosphate reduction or PDR during a dialysis treatment is the algebraic sum, of phosphate cellular flux (removal or captation) and of phosphate tissular precipitation. High bicarbonate levels induce an intracellular shift of phosphate, thus not available for dialytic removal. On the contrary, acidosis prevents P shifting into the intracellular space, thus more P is available for dialytic removal. In order to evaluate cellular phosphate sequestration (CPS) we tested PDR in a crossover study. Three children were dialyzed (18 sessions) successively using either biofiltration with free buffer dialysate and a constant bicarbonate fluid infusion rate (BF) or using sequential biofiltration (SBF) with an initial controlled acidosis period realized by bicarbonate reinjection fluid rate modelling. PDR was higher in SBF (32 +/- 4 mmol/session) than in BF (24 +/- 6 mmol/session). SBF seemed to be efficient against CPS; it clearly demonstrates that bicarbonate modelling is a promising dialytic approach to enhance PDR. The real clinical relevance of these biological results needs clinical long-term evaluation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436307     DOI: 10.1159/000187025

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

Review 1.  Hemodialysis in children: general practical guidelines.

Authors:  M Fischbach; A Edefonti; C Schröder; A Watson
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

Review 2.  Hemodiafiltration: the addition of convective flow to hemodialysis.

Authors:  Michel Fischbach; Helen Fothergill; Arianne Zaloszyc; Laure Seuge
Journal:  Pediatr Nephrol       Date:  2011-02-06       Impact factor: 3.714

3.  Calcium and phosphate balance in adolescents on home nocturnal haemodialysis.

Authors:  Daljit K Hothi; Elizabeth Harvey; Elizabeth Piva; Laura Keating; Donna Secker; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

4.  Paediatric experience with acetate-free biofiltration.

Authors:  M Espino Hernandez; D Morales San Jose; A Luque de Pablos
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

Review 5.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

Authors:  G Klaus; A Watson; A Edefonti; M Fischbach; K Rönnholm; F Schaefer; E Simkova; C J Stefanidis; V Strazdins; J Vande Walle; C Schröder; A Zurowska; M Ekim
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.